ROYAL BANK OF CANADA - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637139. A total of 13 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$0–22
+10.0%
0.00%–
Q1 2023$0–200.0%0.00%–
Q4 2022$0–200.0%0.00%–
Q3 2022$0–20–0.00%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders